Cargando…
Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?
In resectable colorectal liver metastasis (CRLM) the role and use of molecular biomarkers is still controversial. Several biomarkers have been linked to clinical outcomes in CRLM, but none have so far become routine for clinical decision making. For several reasons, the clinical risk score appears t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348630/ https://www.ncbi.nlm.nih.gov/pubmed/28344745 http://dx.doi.org/10.4251/wjgo.v9.i3.98 |